FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I), where Ar1, Ar2, L, R1 are defined in the claims, effective as modulators of the aromatic hydrocarbon receptor (AhR), a pharmaceutical composition containing compounds for modulating AhR or preventing or treating a disease, disorder or condition associated with AhR activity, as an active ingredient.
EFFECT: invention can be used as a drug for preventing or treating a disease, disorder or condition associated with the activity of AhR, in particular, a malignant tumour, a cancer condition, a tumour, a fibrous disease, a condition with uncontrolled immune responses.
21 cl, 2 tbl, 96 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIMIDINE DERIVATIVE THAT SUPPRESSES CANCER CELL GROWTH AND MEDICAL APPLICATION THEREOF | 2020 |
|
RU2792849C1 |
| NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATION OF CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS) | 2015 |
|
RU2684396C2 |
| DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587981C2 |
| SODIUM CHANNEL BLOCKERS, PREPARATION METHOD THEREOF AND USE THEREOF | 2013 |
|
RU2645711C2 |
| HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR | 2018 |
|
RU2783723C2 |
| DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587493C2 |
| HETEROARYL DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A METHOD FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAID ACTIVE SUBSTANCE | 2016 |
|
RU2719367C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| COMPOUNDS AND A COMPOSITION FOR MODULATING THE KINASE ACTIVITY OF EGFR MUTANTS | 2015 |
|
RU2727700C2 |
| 2-CYANOPYRIMIDINE-4-YL CARBAMATE, OR A UREA DERIVATIVE, OR ITS SALT AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2019 |
|
RU2788740C2 |
